The FDA authorization for NVAX's updated COVID-19 vaccine makes it the only non-mRNA vaccine option in the country.

European Commission approves expanded use of Merck's Keytruda in bladder cancer. Sanofi & Lilly announce data from phase III studies on pipeline...

A new study finds that people who stay up late face a 46% higher risk of developing type 2 diabetes compared to early sleepers.

A new study finds that people who stay up late face a 46% higher risk of developing type 2 diabetes compared to early sleepers.

The FDA removes the partial clinical holds on Rezolute's phase III study evaluating RZ358 for treating congenital hyperinsulinism.

The FDA removes the partial clinical holds on Rezolute's phase III study evaluating RZ358 for treating congenital hyperinsulinism.

WASHINGTON, USA – New research being presented at the annual meeting of the European Association for the Study of Diabetes (EASD) in Madrid, Spain...

WASHINGTON, USA – New research being presented at the annual meeting of the European Association for the Study of Diabetes (EASD) in Madrid, Spain...

TUESDAY, Sept. 10, 2024 -- Higher consumption of oats, gluten-containing cereals, and fruits by young children is associated with an increased risk...

TUESDAY, Sept. 10, 2024 -- Taking steroids more than doubles a person’s risk of developing type 2 diabetes, a new study warns.Patients taking...